Purine nucleotide synthesis enzyme

Purine nucleotide synthesis enzymes comprise a group of enzymes catalyzing the de novo and salvage biosynthesis of purine nucleotides, including ATP and GTP, which are essential for nucleic acid synthesis, energy transfer, signal transduction, and cellular proliferation. The primary pathway begins with the generation of phosphoribosyl pyrophosphate (PRPP), followed by a series of reactions catalyzed by enzymes such as PRPP synthetase, PRPP amidotransferase, GAR synthetase, and IMP dehydrogenase, leading to inosine monophosphate (IMP), the common precursor to AMP and GMP. These enzymes are tightly regulated by feedback inhibition and allosteric mechanisms to maintain cellular nucleotide balance. Dysregulation of these enzymes is linked to proliferative diseases (notably cancer), immunodeficiencies, and inherited metabolic disorders. Because of their central role in rapidly dividing cells, purine nucleotide synthesis enzymes are established targets for antimetabolite drugs in cancer and immune modulation.

Other names

Enzymes of de novo purine biosynthesisPurine biosynthetic enzymesPurine metabolism enzymesPurine pathway enzymes

Competitive inhibition (purine analogues) Feedback inhibition (AMP, GMP, IMP inhibit PRPP amidotransferase) Allosteric regulation